Merit Medical Systems, Inc. (MMSI) |
|
67.65 0.32 (0.48%)
|
09-27 11:44 |
|
Open: |
67.74 |
Pre. Close: |
67.33 |
|
High:
|
68.2 |
Low:
|
67.65 |
|
Volume:
|
37,079 |
Market Cap:
|
3,899(M) |
|
|
|
Technical analysis |
as of: 2023-09-27 11:18:34 AM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
  |
| Target: |
Six months: 81.71 One year: 95.44 |
| Support: |
Support1: 65.45 Support2: 62.66 |
| Resistance: |
Resistance1: 69.95 Resistance2: 81.71 |
| Pivot: |
67.3  |
| Moving Average: |
MA(5): 67.99 MA(20): 66.75
MA(100): 76.43 MA(250): 72.42 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.7 |
| Stochastic oscillator: |
%K(14,3): 72.4 %D(3): 73.3 |
| RSI: |
RSI(14): 50.2 |
| 52-week: |
High: 85.62 Low: 54.65 |
| Average Vol(K): |
3-Month: 349 (K) 10-Days: 367 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MMSI ] has closed below upper band by 37.7%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
68.46 - 68.86 |
68.86 - 69.21 |
|
Low:
|
66.32 - 66.75 |
66.75 - 67.14 |
|
Close:
|
66.72 - 67.4 |
67.4 - 68.02 |
|
Company Description |
|
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. |
Headline News |
Wed, 27 Sep 2023
Merit Medical Systems (NASDAQ:MMSI) Rating Reiterated by ... - MarketBeat
Mon, 25 Sep 2023
AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes ... - Investing.com UK
Tue, 19 Sep 2023
Should You Invest in the Invesco S&P SmallCap Health Care ETF ... - Nasdaq
Fri, 15 Sep 2023
Putnam Investments LLC Has $15.89 Million Stock Position in Merit ... - MarketBeat
Wed, 06 Sep 2023
Merit Medical Launches the Aspira® Evacuated Drainage Bottle - GlobeNewswire
Wed, 30 Aug 2023
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
58 (M) |
| Shares Float |
56 (M) |
|
% Held by Insiders
|
2.2 (%) |
|
% Held by Institutions
|
96.7 (%) |
|
Shares Short
|
1,040 (K) |
|
Shares Short P.Month
|
664 (K) |
Stock Financials |
|
EPS
|
1.52 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
20.88 |
|
Profit Margin (%)
|
7.4 |
|
Operating Margin (%)
|
9.1 |
|
Return on Assets (ttm)
|
3.9 |
|
Return on Equity (ttm)
|
7.8 |
|
Qtrly Rev. Growth
|
8.5 |
|
Gross Profit (p.s.)
|
9 |
|
Sales Per Share
|
20.81 |
|
EBITDA (p.s.)
|
3.35 |
|
Qtrly Earnings Growth
|
29.7 |
|
Operating Cash Flow
|
95 (M) |
|
Levered Free Cash Flow
|
33 (M) |
Stock Valuations |
|
PE Ratio
|
44.53 |
|
PEG Ratio
|
2 |
|
Price to Book value
|
3.26 |
|
Price to Sales
|
3.27 |
|
Price to Cash Flow
|
41.2 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
